For people whose deficiency is caused by an absorption problem, injections are the more dependable option
Comparative Growth Hormone Fragment Studies : Comparing AOD 9604 with full-length human growth hormone and other C-terminal fragments to better understand which regions of the hormone drive specific metabolic effects and which pathways operate independently of classical GH receptor signaling
For the maintenance treatment of pernicious anemia, the usual dose is 100mcg SC/IM, given once every month
Researchers and clinicians have studied its potential applications in body recomposition, stubborn fat reduction, and metabolic support, particularly in individuals who have not responded adequately to diet and exercise interventions alone
By enhancing fat mobilization and oxidation, AOD-9604 provides alternative fuel sources that reduce the need for the body to break down muscle protein for energy during caloric deficit
Not for human consumption, medical use, or diagnostic purposes